GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q3 2021
Top Holdings61 positions
TENET HEALTHCARE CORP | 8.7M | $574.9M | 10.4% | $17.82 | +272.92% | 12 qtrssince 2018-Q4 | Decreased 0 |
BAUSCH HEALTH COS INC | 15.6M | $435.8M | 7.9% | $22.59 | +23.30% | 12 qtrssince 2018-Q4 | Decreased 0 |
MCKESSON CORP | 1.7M | $345.1M | 6.3% | $144.46 | +39.02% | 12 qtrssince 2018-Q4 | Increased 70 |
THE CIGNA GROUP | 1.3M | $264.8M | 4.8% | $177.65 | +2.67% | 12 qtrssince 2018-Q4 | Increased 58 |
CENCORA INC | 1.9M | $225.3M | 4.1% | $93.50 | +23.81% | 12 qtrssince 2018-Q4 | Increased 62 |
GLOBAL PMTS INC | 1.3M | $210.6M | 3.8% | $172.59 | -13.15% | 4 qtrssince 2020-Q4 | Increased 76 |
WILLIS TOWERS WATSON PLC LTD | 832,798 | $193.6M | 3.5% | $217.42 | 0.00% | 1 qtr | New 85 |
DXC TECHNOLOGY CO | 5.6M | $188.3M | 3.4% | $47.55 | -29.31% | 12 qtrssince 2018-Q4 | Decreased 0 |
BAXTER INTL INC | 2.2M | $174.4M | 3.2% | $73.69 | -1.05% | 7 qtrssince 2020-Q1 | Increased 87 |
ALPHABET INC | 50,262 | $134.4M | 2.4% | $93.50 | +41.63% | 12 qtrssince 2018-Q4 | Decreased 0 |
TAKEDA PHARMACEUTICAL CO LTD | 8.1M | $132.7M | 2.4% | $18.73 | +5.02%as of Oct 16 | 11 qtrssince 2019-Q1 | Decreased 0 |
CENTENE CORP DEL | 2.1M | $132.2M | 2.4% | $72.42 | -13.96% | 2 qtrssince 2021-Q2 | Increased 54 |
HCA HEALTHCARE INC | 525,237 | $127.5M | 2.3% | $119.49 | +103.51% | 12 qtrssince 2018-Q4 | Decreased 0 |
APTIV PLC | 823,467 | $122.7M | 2.2% | $149.18 | +0.98% | 4 qtrssince 2020-Q4 | Increased 74 |
UNIVERSAL HLTH SVCS INC | 879,079 | $121.6M | 2.2% | $115.43 | +21.38% | 12 qtrssince 2018-Q4 | Decreased 0 |
COCA-COLA EUROPACIFIC PARTNE | 2.2M | $121.4M | 2.2% | $46.79 | +1.84% | 3 qtrssince 2021-Q1 | Decreased 0 |
UBER TECHNOLOGIES INC | 2.4M | $109M | 2.0% | $45.70 | -2.59% | 2 qtrssince 2021-Q2 | Increased 76 |
PARAMOUNT GLOBAL | 2.7M | $105.4M | 1.9% | — | — | 8 qtrssince 2019-Q4 | Decreased 0 |
DUPONT DE NEMOURS INC | 1.5M | $103.5M | 1.9% | $84.53 | -8.33% | 4 qtrssince 2020-Q4 | Increased 57 |
CORTEVA INC | 2.2M | $93.6M | 1.7% | $4.95 | +20.99% | 8 qtrssince 2019-Q4 | Decreased 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $5.5B across 61 positions as of Q3 2021. Top holdings: THC (10.4%), BHC (7.9%), MCK (6.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 7 new positions, 12 exits, 15 increased. Top move: BAX (INCREASED, conviction 87). Portfolio: $5.5B across 61 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR